BusinessNews

More Indian Pharma Companies Eye Kilinto Industrial Park

ADDIS ABABA – More Indian pharmaceutical companies expressed their interest in engaging in manufacturing inside the Kilinto Industrial Park.

Nearly 40 companies led by the Pharmaceutical Export Promotion Council (Pharmexcil) of India visited the industrial Park following the India-Ethiopia Pharma Conference on Tuesday.

“They are provided with detailed information about the services, investment policies and incentives,” the Industrial Park Development Corporation (IPDC) said in a statement today.

The Corporation currently manages twelve state-owned industrial parks located across Ethiopia. It’s Investment Promotion and Marketing Junedin told the Indian delegation that Kilinto IP is dedicated to the pharmaceutical sector.

The Park – built on 279 hectares of land – is hosting international and local manufacturers including India’s Kilitch Drugs Ltd and Glocare Pharma Manufacturing Plc.

The participation of Indian investors inside Kilinto IP is growing, Deputy CEO Zemen said.

The IPDC will provide all necessary support to international and local investors keen to engage in the sector, he told the visiting delegation.

After their tour of the infrastructure and service delivery in the park, “the investors expressed their desire to invest in the Park after their visit to the facility,” the IPDC said.

Kilinto Industrial Park is a site dedicated by the government, especially for medical products manufacturing. The decision is part of a plan to substitute up to 60% of Ethiopia’s pharmaceutical imports with locally produced products within four years.

Ethiopia spends more than a billion US dollars annually to meet 85% of its pharmaceutical drug demand.